PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

January 21, 2025

Study Completion Date

January 21, 2025

Conditions

Diabetes Mellitus, Type 2Diastolic Dysfunction

Interventions

DRUG

LCZ 696

Participants will receive Oral LCZ 696 (Entresto 97/103 mg)

DRUG

Placebos

Participants will receive 1oral Placebo capsule

Trial Locations (1)

Mayo Clinic in Rochester, Rochester